TCG Lifesciences discovery research business unit - Chembiotek, is one of the leading contract drug discovery research organisations in India. Chembiotek provides chemistry, biology and pre-clinical research services and was named “Best chemistry based CRO in Asia” in 2006 by one of the world’s largest pharmaceutical company.
Business:
Chembiotek is one of the leading providers of drug discovery research services in India. It offers a unique opportunity to create molecular assets. The medicinal chemistry / compound design, synthetic chemistry and biology / compound evaluation teams work in unison to generate and progress leads for specific drug targets to the stage of kilo scale synthesis for first-in-man material. The teams at Chembiotek have discovered many New Chemical Entities (NCE) for the customers and have extensive experience with GPCRs, NHRs, Kinases, Proteases and other enzymes.
Value Proposition:
TCG Lifesciences has established integrated drug discovery research programs for drug design to lead optimization molecules creating molecular assets with the ability to take it forward to kilo scale synthesis for first-in-human material. Chembiotek leverages this platform to engage with global large and mid-market pharmaceutical and biotechnology companies by adding value - offering high quality and low cost.
